On April 17, 2024, Exact Sciences Corporation closed the transaction. The company issued 1.75% Senior Unsecured Convertible Notes due April 15, 2031 for a principal amount of $266,750,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.14 USD | 0.00% | -7.49% | -43.04% |
06-11 | Exact Sciences Seeks Acquisitions | CI |
06-11 | Transcript : Exact Sciences Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 03:20 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.04% | 7.78B | |
+17.71% | 3.9B | |
+4.92% | 2.39B | |
-19.94% | 2.01B | |
-19.77% | 1.69B | |
+20.31% | 1.05B | |
+27.42% | 796M | |
-9.83% | 696M | |
-29.39% | 510M | |
-6.96% | 275M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation announced that it has received $266.75 million in funding